Epodure trial a go for Medgenics
The FDA cleared a Phase IIb trial of Medgenics‘s (NYSE:MDGN) Epodure anemia treatment for patients undergoing renal dialysis.
Read more
Ekso Bionics wins CE Mark for exoskeleton
Ekso Bionics said it won CE Mark approval for its bionic exoskeletons designed to let the wheelchair-bound walk.
Read more
Sign up to get our free newsletters delivered right to your inbox
Mauna Kea wins clearance for Cellvizio Miniprobes
Mauna Kea (ENT:MKEA) Technologies said the FDA cleared a portfolio of smaller Cellvizio Miniprobes.
Read more